FDA authorizes Bioiberica’s customers to commercialize their heparinAfter adapting to the new and complex requirements of the USP (United States Pharmacopea), and having successfully passed the FDA (Food and Drug Administration) inspection of our installations, this organization has communicated that Bioibérica is prepared to market their active ingredient Heparin in the USA.
